journal
MENU ▼
Read by QxMD icon Read
search

Cardiovascular Intervention and Therapeutics

journal
https://www.readbyqxmd.com/read/29752590/peri-stent-contrast-staining-post-everolimus-eluting-stent-deployment-disappeared-in-a-very-short-duration
#1
Takuya Maeda, Tomohiko Teramoto, Nobukiyo Tanaka, Hiroki Ishihara, Masanori Teramura, Kei Ichihashi
No abstract text is available yet for this article.
May 11, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29736670/impact-of-shorter-door-to-balloon-time-on-prognosis-of-patients-with-stemi-single-center-analysis-with-a-large-proportion-of-the-patients-treated-within-30-min
#2
Takeshi Yamada, Akihiko Takahashi, Yukio Mizuguchi, Sho Hashimoto, Norimasa Taniguchi, Shunsuke Nakajima, Tetsuya Hata
Several recent studies suggested that the door-to-balloon time (DTBT) for patients with ST-segment elevation myocardial infarction (STEMI) should be as short as possible, despite the existing guideline for STEMI. This study aimed to evaluate the clinical outcomes of the STEMI patient cohort having the highest proportion of patients treated with a DTBT of ≤ 30 min ever reported. We evaluated 527 consecutive patients with STEMI who underwent percutaneous coronary intervention between 2007 and 2015. The mean age was 68...
May 7, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29730853/renalguard-system-to-prevent-contrast-induced-acute-kidney-injury-in-japanese-patients-with-renal-dysfunction-respect-kidney-study
#3
Hiromasa Katoh, Tsuyoshi Nozue, Kazuki Horie, Takashi Sozu, Naoto Inoue, Ichiro Michishita
Increasing the urine flow rate (UFR) reduces the toxic effect of contrast media. Use of the RenalGuard system enables the achievement of a high UFR by maintaining intravascular volume and prevents the development of contrast-induced acute kidney injury (CI-AKI). However, the efficacy and safety of RenalGuard system have not yet been evaluated in Japan. This multicenter prospective study evaluated the efficacy and safety of the RenalGuard therapy in preventing CI-AKI development in 60 Japanese patients with renal dysfunction [estimated glomerular filtration rate (eGFR) < 45 mL/min/1...
May 5, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29730852/iliac-artery-stent-fracture-associated-with-hip-joint-flexion
#4
Takahito Doi, Osami Kawarada, Takeshi Yagyu, Teruo Noguchi, Satoshi Yasuda
No abstract text is available yet for this article.
May 5, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29728931/the-rotawire-may-be-spinning-in-rotational-atherectomy-under-the-maximum-rotational-speed
#5
Kenichi Sakakura, Shin-Ichi Momomura, Hideo Fujita
No abstract text is available yet for this article.
May 4, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29700794/entrapment-of-dissection-flap-and-intimal-tissue-cleavage-during-rotational-atherectomy
#6
Enrico Fabris, Mark Kennedy, Elvin Kedhi, Jan Paul Ottervanger
No abstract text is available yet for this article.
April 26, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29700793/prophylactic-use-of-thoracic-endovascular-aortic-repair-in-a-young-patient-with-impending-aortic-rupture
#7
Rafath Ullah, M Fuad Jan, Puneet Menaria, Joseph R Whitnah, John Crouch, Tanvir Bajwa
No abstract text is available yet for this article.
April 26, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29691767/prognostic-impact-of-final-kissing-balloon-technique-after-crossover-stenting-for-the-left-main-coronary-artery-from-the-aoi-lmca-registry
#8
Koji Nishida, Mamoru Toyofuku, Takeshi Morimoto, Masanobu Ohya, Yasushi Fuku, Hirooki Higami, Kyohei Yamaji, Hiromi Muranishi, Yuhei Yamaji, Daisuke Furukawa, Tomohisa Tada, Euihong Ko, Kazushige Kadota, Kenji Ando, Hiroki Sakamoto, Takashi Tamura, Kazuya Kawai, Takeshi Kimura
It is still uncertain whether the final kissing balloon technique (FKBT) is mandatory after crossover stenting for the left main coronary artery (LMCA). Assessing Optimal Percutaneous Coronary Intervention for LMCA (AOI-LMCA) registry, a 6-center retrospective registry, enrolled 1809 consecutive patients for LMCA stenting in Japan. In the present analysis, 5-year clinical outcomes were compared between non-FKBT (n = 160) and FKBT (n = 578) groups in patients treated with crossover stenting with drug-eluting stents from the LMCA to the left anterior descending artery...
April 24, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29654408/contemporary-critical-limb-ischemia-asian-multidisciplinary-consensus-statement-on-the-collaboration-between-endovascular-therapy-and-wound-care
#9
REVIEW
Osami Kawarada, Kan Zen, Koji Hozawa, Shinobu Ayabe, Hsuan-Li Huang, Donghoon Choi, Su Hong Kim, Jiyoun Kim, Taku Kato, Yoshinori Tsubakimoto, Tasuya Nakama, Shigeo Ichihashi, Naoki Fujimura, Akihiro Higashimori, Masahiko Fujihara, Tomoyasu Sato, Bryan Ping-Yen Yan, Skyi Yin-Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Robbie K George, Yoshiaki Yokoi, Hisashi Motomura, Hideaki Obara
The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital...
April 13, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29611133/satisfactory-arterial-healing-after-second-generation-drug-eluting-stent-implantation-for-segmental-stenosis-in-a-patient-with-kawasaki-disease
#10
Shota Okuno, Takayuki Ishihara, Osamu Iida, Shin Okamoto, Kiyonori Nanto, Toshiaki Mano
No abstract text is available yet for this article.
April 2, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29594964/cvit-expert-consensus-document-on-primary-percutaneous-coronary-intervention-pci-for-acute-myocardial-infarction-ami-in-2018
#11
REVIEW
Yukio Ozaki, Yuki Katagiri, Yoshinobu Onuma, Tetsuya Amano, Takashi Muramatsu, Ken Kozuma, Satoru Otsuji, Takafumi Ueno, Nobuo Shiode, Kazuya Kawai, Nobuhiro Tanaka, Kinzo Ueda, Takashi Akasaka, Keiichi Igarashi Hanaoka, Shiro Uemura, Hirotaka Oda, Yoshiaki Katahira, Kazushige Kadota, Eisho Kyo, Katsuhiko Sato, Tadaya Sato, Junya Shite, Koichi Nakao, Masami Nishino, Yutaka Hikichi, Junko Honye, Tetsuo Matsubara, Sumio Mizuno, Toshiya Muramatsu, Taku Inohara, Shun Kohsaka, Ichiro Michishita, Hiroyoshi Yokoi, Patrick W Serruys, Yuji Ikari, Masato Nakamura
While primary percutaneous coronary intervention (PCI) has significantly contributed to improve the mortality in patients with ST segment elevation myocardial infarction even in cardiogenic shock, primary PCI is a standard of care in most of Japanese institutions. Whereas there are high numbers of available facilities providing primary PCI in Japan, there are no clear guidelines focusing on procedural aspect of the standardized care. Whilst updated guidelines for the management of acute myocardial infarction were recently published by European Society of Cardiology, the following major changes are indicated; (1) radial access and drug-eluting stent over bare metal stent were recommended as Class I indication, and (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation...
March 29, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29582354/repeat-transcatheter-aortic-valve-replacement-using-a-23-mm-evolut-r-in-a-small-patient-with-a-failed-20-mm-sapien-xt
#12
Mike Saji, Tetsuya Tobaru, Ryosuke Higuchi, Shuichiro Takanashi, Morimasa Takayama, Mitsuaki Isobe
No abstract text is available yet for this article.
March 26, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29508236/mortality-impact-of-post-discharge-myocardial-infarction-size-after-percutaneous-coronary-intervention-a-patient-level-pooled-analysis-from-the-4-large-scale-japanese-studies
#13
Hirotoshi Watanabe, Takeshi Morimoto, Hiroki Shiomi, Yusuke Yoshikawa, Takao Kato, Naritatsu Saito, Satoshi Shizuta, Koh Ono, Kyohei Yamaji, Kenji Ando, Shuichiro Kaji, Yutaka Furukawa, Masaharu Akao, Tetsuya Ishikawa, Takashi Tamura, Yoshito Yamamoto, Toshiya Muramatsu, Satoru Suwa, Yoshihisa Nakagawa, Kazushige Kadota, Yoshiki Takatsu, Hideo Nishikawa, Yoshikazu Hiasa, Yasuhiko Hayashi, Shunichi Miyazaki, Takeshi Kimura
It is unknown whether there is a threshold of creatine kinase (CK) or CK-MB affecting the subsequent mortality for post-discharge myocardial infarction (PDMI) after percutaneous coronary intervention. Current study sought to evaluate the impact of PDMI. The study population included 30,051 patients with successful coronary stenting and discharged alive in the pooled patient-level database of 4 Japanese studies (j-Cypher registry, CREDO-Kyoto PCI/CABG registry cohort-2, RESET, and NEXT). During 4.4 ± 1...
March 5, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29484580/five-year-clinical-outcomes-of-everolimus-eluting-stents-from-the-post-marketing-study-of-cocr-ees-xience-v-promus-in-japan
#14
Jiro Aoki, Ken Kozuma, Masaki Awata, Mamoru Nanasato, Nobuo Shiode, Kengo Tanabe, Junichi Yamaguchi, Hajime Kusano, Hong Nie, Takeshi Kimura
The Cobalt Chromium Everolimus-Eluting Stent (CoCr-EES) Post Marketing Surveillance (PMS) Japan study is a prospective multicenter registry designed to evaluate the safety and efficacy of XIENCE V/PROMUS everolimus-eluting stents in routine clinical practice at 47 centers representative of the clinical environment in Japan. We enrolled 2010 consecutive patients (2649 lesions) who underwent percutaneous coronary intervention using CoCr-EES. Clinical outcomes were evaluated through 5 years. Mean age was 68.8 years, 41...
February 26, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29476418/easily-size-adjustable-homemade-snare-effective-for-bailout-of-kinked-guiding-catheter
#15
Daisuke Miyawaki, Tetsuya Nomura, Hiroshi Kubota, Masakazu Kikai, Natsuya Keira, Tetsuya Tatsumi
No abstract text is available yet for this article.
February 23, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29426986/the-picking-technique-for-self-expanding-nitinol-stent-expansion-of-an-extremely-calcified-lesion-in-the-femoropopliteal-artery-the-tail-makes-the-difference
#16
Sayaka Funabashi, Osami Kawarada, Takeshi Yagyu, Teruo Noguchi, Satoshi Yasuda
No abstract text is available yet for this article.
February 9, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29363045/percutaneous-closure-of-iatrogenic-ventricular-septal-rupture-following-septal-branch-obstruction-during-elective-coronary-angioplasty
#17
Takashi Yanagiuchi, Norio Tada, Yusuke Enta, Masaki Hata, Hideki Abe, Tatsushi Ootomo
No abstract text is available yet for this article.
January 23, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29349686/two-year-results-after-coronary-stenting-of-small-vessels-in-japanese-population-using-2-25-mm-diameter-sirolimus-eluting-stent-with-bioresorbable-polymer-primary-and-long-term-outcomes-of-century-jsv-study
#18
Shigeru Saito, Kenji Ando, Yoshiaki Ito, Tetsuya Tobaru, Junji Yajima, Takeshi Kimura, Kazushige Kadota
Percutaneous coronary intervention (PCI) in coronary artery disease (CAD) with very small vessels remains challenging. The aim of this study is to evaluate the safety and effectiveness of the 2.25-mm diameter Ultimaster sirolimus-eluting stent in the treatment of Japanese patients with CAD due to lesions in very small vessels. The CENTURY JSV study is a prospective, multicentre, single-arm study. Seventy patients with lesions deemed suitable for implantation of a 2.25-mm diameter stent were enrolled at seven hospitals in Japan...
January 18, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29335827/satisfactory-arterial-repair-1-year-after-ultrathin-strut-biodegradable-polymer-sirolimus-eluting-stent-implantation-an-angioscopic-observation
#19
Takayuki Ishihara, Masaki Awata, Osamu Iida, Masashi Fujita, Masaharu Masuda, Shin Okamoto, Kiyonori Nanto, Takashi Kanda, Takuya Tsujimura, Masaaki Uematsu, Toshiaki Mano
The ultrathin strut biodegradable polymer sirolimus-eluting stent (Orsiro, O-SES) exhibits satisfactory clinical outcomes. However, no report to date has documented the intravascular status of artery repair after O-SES implantation. We examined 5 O-SES placed in 4 patients (age 65 ± 12 years, male 75%) presenting with stable angina pectoris due to de novo lesions in native coronary arteries. Coronary angioscopy was performed immediately after percutaneous coronary intervention and 1 year later. Angioscopic images were analyzed to determine the following: (1) dominant grade of neointimal coverage (NIC) over the stent; (2) maximum yellow plaque grade; and (3) existence of thrombus...
January 15, 2018: Cardiovascular Intervention and Therapeutics
https://www.readbyqxmd.com/read/29322477/aortic-stenosis-with-right-sided-aortic-arch-treated-with-transfemoral-aortic-valve-implantation
#20
Fumiaki Yashima, Kentaro Hayashida, Masahito Munakata, Takahide Arai, Hideyuki Shimizu, Keiichi Fukuda
No abstract text is available yet for this article.
January 10, 2018: Cardiovascular Intervention and Therapeutics
journal
journal
42825
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"